FDA Approves Ankle-Replacement System

The U.S. Food and Drug Administration has approved the Scandinavian Total Ankle Replacement (S.T.A.R.) System for patients with arthritic or deformed ankles.

Read more »

Burrill Report: Financing Activity May Lift Cloud Hanging Over Biotech Industry

While biotech leaders from all over the world gathered at the 2009 BIO International Convention in Atlanta, financing activity in the sector raised hope that the cloud hanging over the industry may be lifting a little.

Read more »

SyntheMed’s REPEL-CV Approved by Australian Regulators

REPEL-CV, an anti-adhesion barrier developed by biomaterials company SyntheMed, has received approval by the Australian Therapeutic Goods Administration for use in open-heart surgery.

Read more »

Explore Investment and Networking Opportunities at IN3 East

Hundreds of companies such as Bain Capital Ventures, Becton Dickinson, Covidien, DePuy Mitek Worldwide, Kimberly-Clark, Medtronic, Novartis BioVenture Fund, Quaker […]

Read more »

Sonitus Medical Attracts CIA Dollars

Sonitus Medical Inc., developer of a non-surgical hearing aid that is designed to transmit sound via the teeth, announced that it has received an investment from In-Q-Tel, a strategic investment firm that was started by the CIA.

Read more »

Biogen Idec, Electro-Optical Among “5 Stocks Approaching Greatness”

Investment website The Motley Fool has published a list of five stocks approaching greatness–and four of them are within the life sciences industry.

Read more »

Clarient Stock Deal Frees Up Cash for Safeguard Scientifics

Safeguard Scientifics Inc. has received $19.5 million in cash, and freed up another $12.3 million in cash due to one of its portfolio companies completing the second part of a private placement of convertible preferred stock.

Read more »

Compounds in Plant DNA May Help Humans

That little houseplant sitting on your windowsill could one day save your life.

Read more »

TargetScan Touch Proven Effective in Duke Study

A study published in Technology in Cancer Research and Treatment shows that Envisioneering Medical’s TargetScan Touch system is more effective in detecting prostate cancer than traditional biopsy methods.

Read more »

TearLab Gets FDA 510(k) Approval

TearLab Corporation has received FDA 510(k) clearance of its TearLab Osmolarity System.

Read more »